These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Merosin and congenital muscular dystrophy. Miyagoe-Suzuki Y; Nakagawa M; Takeda S Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965 [TBL] [Abstract][Full Text] [Related]
12. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Pegoraro E; Mancias P; Swerdlow SH; Raikow RB; Garcia C; Marks H; Crawford T; Carver V; Di Cianno B; Hoffman EP Ann Neurol; 1996 Nov; 40(5):782-91. PubMed ID: 8957020 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin. Qiao C; Li J; Zhu T; Draviam R; Watkins S; Ye X; Chen C; Li J; Xiao X Proc Natl Acad Sci U S A; 2005 Aug; 102(34):11999-2004. PubMed ID: 16103356 [TBL] [Abstract][Full Text] [Related]
14. CD90-positive cells, an additional cell population, produce laminin alpha2 upon transplantation to dy(3k)/dy(3k) mice. Fukada S; Yamamoto Y; Segawa M; Sakamoto K; Nakajima M; Sato M; Morikawa D; Uezumi A; Miyagoe-Suzuki Y; Takeda S; Tsujikawa K; Yamamoto H Exp Cell Res; 2008 Jan; 314(1):193-203. PubMed ID: 17963748 [TBL] [Abstract][Full Text] [Related]
15. Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle. Cohn RD; Mayer U; Saher G; Herrmann R; van der Flier A; Sonnenberg A; Sorokin L; Voit T J Neurol Sci; 1999 Mar; 163(2):140-52. PubMed ID: 10371075 [TBL] [Abstract][Full Text] [Related]
16. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231 [TBL] [Abstract][Full Text] [Related]